Related Keywords

District Of Columbia ,United States ,New York ,Ohio ,Montana ,Puerto Rico ,Kentucky ,Michigan ,Pennsylvania ,Alabama ,Delaware ,Arkansas ,Louisiana ,Oklahoma ,Virginia ,American ,Ruth Blatt ,Terry Simananda ,Michael Forman ,Xavier Becerra ,Christine Hinds ,America Ph ,Operations Research Analysts ,Third Party Liability ,Medicare Drug Price Negotiation Program ,Human Services ,B Drug Pricing Program ,Office Of The Inspector ,Office Of Inspector ,Program Integrity ,Department Of Health ,National Drug Codes ,Operations Research Analyst ,American Hospital Formulary Service ,National Occupational Employment ,Allergan Sales ,Operations Research Analysts Code ,Program Administration Proposed ,Recordkeeping Requirements Under The Drug Rebate Program ,Centers For Disease ,Regulatory Affairs ,Consistent With Court Order ,Allergan ,National Average Drug Acquisition Cost ,National Council For Prescription Drug Programs ,Public Health Service ,Small Business Administration ,B Research ,National Drug Code ,B Drug Pricing Program Or Medicare Part ,Health Resources ,National Drug Rebate Agreement ,Medicaid Services Investment ,B Program ,Medicaid Program ,Office Of Management ,Department Of Justice ,Centers For Medicare Medicaid Services ,Vaccines For Children Program ,Agency Authority To Correct Misclassifications ,Purposes Of Determininga Base Date ,Department Of Veterans Affairs ,United States Court ,Drug Administration ,Clearance Office ,United States District Court ,Government Survey For States ,Government Survey For Manufacturers ,Children Health Insurance Program ,Services Administration ,Office Of Information ,Us Bureau Of Labor Statistic ,Medicaid Drug Rebate Program ,Advisory Committee On Immunization Practices ,Requirements Related To Third Party Vendors ,End Amendment Partstart Authority ,Congressional Budget Office ,Operations Research Analyst Code ,Processing Bank Identification Number ,Start Preamblestart Printed Page ,Medicaid Services ,Accountability Act ,Bipartisan Budget Act ,Establishing Minimum Standards ,Medicaid State Drug Utilization Review ,Supporting Value Based Purchasing ,Drugs Covered ,Revising Medicaid Drug Rebate ,Best Price ,Average Manufacturer Price ,Beneficiary Identification Number ,Processor Control Number ,Regulatory Impact Analysis ,End Further Infoend Preamblestart Supplemental ,Public Comments ,Social Security Act ,Federal Financial Participation ,Start Printed Page ,State Plan ,Average Manufacturer ,Consumer Price Index ,All Urban Consumers ,Covered Outpatient Drug ,Federal Food ,Cosmetic Act ,Biologics License Application ,Manufacturer Release ,Amendments Made ,Fact Regarding ,Classification Enforcement ,Drugs Under ,Inspector General ,Product Labeling ,Data Elements ,Single Source Drug ,Innovator Multiple Source ,Printed Page ,Multiple Source Drug ,Abbreviated New Drug Application ,Administration Proposed ,Covered Outpatient ,Internal Investigation ,Pricing Metric ,Time Limitation ,Price Recalculations ,Recordkeeping Requirements Under ,Drug Rebate ,Market Date ,Base Date ,State Medicaid ,Noninnovator Multiple Source ,Health Insurance Program ,Disease Control ,Determining Best ,Audits Over Utilization Data With States ,Quarter Rebate Dispute Time ,Medicaid Drug Rebate ,Regarding Drug Price Verification ,Transparency Through Data ,Average Sales Price ,Wholesale Acquisition Cost ,Medicare Prescription Drug ,Modernization Act ,Federal Upper Limits ,Establish Requirements ,Implementing Section ,Conditions Relating ,Deficit Reduction Act ,Drug Pricing Program ,Managed Care Plan Standard Contract ,Medicaid Managed Care Pharmacy Identification ,National Council ,Prescription Drug Programs ,Public Health Service Act ,Drug Pricing ,Drug Cost Transparency ,Medicaid Managed Care ,Medical Loss Ratio ,Consistent With Court ,American Rescue Act ,Manufacturer Rebate Cap ,American Rescue Plan Act ,Issues Relating ,Medicaid Prescriptions ,Third Party Liability Regulation Due ,Cost Transparency ,Average Wholesale Price ,Maximum Allowable Cost ,Informational Bulletin ,Loss Ratio ,Requirements Related ,Third Party ,Ohio Auditor ,Proposal To Modify ,Proposal To Define Drug Product Information ,Drug Data Reporting ,Proposal To Define Internal Investigation ,Pricing Metric Revisions ,Medicaid Drug Product ,Proposal To Revise Definition ,Federal Government ,Manufacturer Releases ,Proposal To Define Market Date ,Noninnovator Multiple Source Drug ,Proposal To Define Vaccine ,Omnibus Budget Reconciliation Act ,Immunization Practices ,Proposal To Account ,Stacking When Determining Best Price ,Fourth Circuit ,Proposal To Rescind Revisions Made ,Pharmaceutical Research ,Drug Classification ,Drug Product Data Reporting Requirements ,Proposals Related ,Medicaid Drug Rebates ,Drug Rebates ,Unpaid Rebate Amounts ,Federal Medicaid ,Manufacturer To Correct Misclassification ,Manufacturer Payment ,Unpaid Rebates Due ,Additional Penalties ,Drug Misclassification ,Civil Monetary Penalty ,Medicare Part ,Manufacturer Misclassification ,Manufacturers Relating ,Drug Category ,Late Reporting ,Drug Product Information ,Affordable Care Act ,Proposal To Clarify ,With Respect ,Proposal To Establish ,Quarter Rebate Audit Time Limitation ,Dispute Resolution ,Estate Release ,State Invoice ,Prior Quarter Adjustment Statement ,Release Number ,Dispute Resolution Process ,Drug Indicator ,State Release Number ,Drug Price Verification Survey Process ,Certain Reported ,Oxford English Dictionary ,Medicaid Federal Upper Limits ,Unit Rebate Amount ,Medicare Drug Price Negotiation ,Inflation Reduction Act ,Executive Order ,Medicaid Financial Management Report ,State Specific Medicaid ,Trade Secrets ,National Drug Rebate ,State Plan Requirements ,State Plan Amendment ,State Medicaid Directors Letter ,Frequently Asked Questions ,Physician Administered Drugs ,Healthcare Common Procedure Coding System ,Physician Administered ,Prescription Drugs ,Final Rule ,Managed Care ,Drug Information ,United States Pharmacopoeia ,Principal Deputy Inspector General ,Chief Medical Officer ,State Federal ,Paperwork Reduction Act ,Federal Register ,Labor Statistic ,Occupational Employment ,Wage Estimates ,Proposed Information Collection Requirements ,Regarding Identification ,Regarding Definitions ,Regarding Proposals Related ,Regarding Federal Financial Participation ,State Drug Utilization Data ,Regarding Verification Survey ,Through Data Collection ,Medicaid Financial Management ,Proposed Burden ,Reports Clearance Office ,Regulatory Planning ,Improving Regulation ,Regulatory Review ,Regulatory Flexibility Act ,Unfunded Mandates Reform Act ,Congressional Review Act ,Budget Office ,Medicaid Managed Care Cards ,Medicaid Managed Care Contracts ,Drug Product ,Define Internal Investigation ,Revise Definition ,Define Market ,Define Vaccine ,Quarter Rebate Audit Time ,Research Analysts ,Stacking When Determining Best ,One Time Quantitative Costs ,Annual Quantitative Costs ,Government Survey ,Review Cost ,Accounting Statement ,Pharmaceutical Preparation Manufacturing ,Biologic Product ,Medicine Manufacturing ,Medicine Manufacturing Size ,Concentration Ratios ,Except Diagnostic ,Medicine Manufactures ,Tribal Governments ,Partstart Amendment ,End Amendment Partstart ,Authoritystart Amendment ,End Amendment ,Urban Consumers ,Veterans Affairs ,Financial Participation ,